Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
EPS for Arbutus Biopharma (ABUS)
EPS in 2023 (TTM): -$0.46
According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is -$0.46. In 2022 the company made an earnings per share (EPS) of -$0.47 an increase over its 2021 EPS that were of -$0.83.
EPS history for Arbutus Biopharma from 2008 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.46 | -2.13% |
| 2022 | -$0.47 | -43.37% |
| 2021 | -$0.83 | -17% |
| 2020 | -$1.00 | -65.4% |
| 2019 | -$2.89 | 138.84% |
| 2018 | -$1.21 | -21.94% |
| 2017 | -$1.55 | -78.59% |
| 2016 | -$7.24 | 440.3% |
| 2015 | -$1.34 | -27.57% |
| 2014 | -$1.85 | 98.92% |
| 2013 | -$0.93 | -143.1% |
| 2012 | $2.16 | -326.77% |
| 2011 | -$0.95 | -20.49% |
| 2010 | -$1.20 | 59.67% |
| 2009 | -$0.75 | -52% |
| 2008 | -$1.56 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$0.06000 | -86.96% | Bahamas |
 NRC Health
NRC | $1.19 | -358.70% | 🇺🇸 USA |